OMEGA THERAPEUTICS IN
1.0700
08-October-24 14:59:13
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
1.0700 - 1.1200
ISIN
N/A
Source
NASDAQ
-
17 Sep 2024 06:00:02 By Nasdaq GlobeNewswire
-
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
14 Aug 2024 06:00:08 By Nasdaq GlobeNewswire
-
06 Aug 2024 06:00:09 By Nasdaq GlobeNewswire
-
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
24 Jun 2024 06:00:53 By Nasdaq GlobeNewswire
-
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
30 May 2024 06:00:59 By Nasdaq GlobeNewswire
-
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
29 May 2024 06:00:17 By Nasdaq GlobeNewswire
-
08 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
06 May 2024 06:00:02 By Nasdaq GlobeNewswire
-
23 Apr 2024 06:00:02 By Nasdaq GlobeNewswire
-
09 Apr 2024 06:00:31 By Nasdaq GlobeNewswire
-
28 Mar 2024 08:15:05 By Nasdaq GlobeNewswire
-
06 Mar 2024 06:00:08 By Nasdaq GlobeNewswire
-
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 15:05:13 By Nasdaq GlobeNewswire
-
04 Dec 2023 15:00:22 By Nasdaq GlobeNewswire
-
Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
20 Nov 2023 15:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 06:00:32 By Nasdaq GlobeNewswire
-
09 Nov 2023 06:00:17 By Nasdaq GlobeNewswire
-
Omega Therapeutics to Participate in The Jefferies London Healthcare Conference
07 Nov 2023 15:00:20 By Nasdaq GlobeNewswire
-
31 Oct 2023 06:00:16 By Nasdaq GlobeNewswire
-
16 Oct 2023 06:00:46 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >